# Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction

> **NCT03171727** · NA · UNKNOWN · sponsor: **West China Hospital** · enrollment: 117 (estimated)

## Conditions studied

- Liver Cirrhosis
- Portal Hypertension

## Interventions

- **DRUG:** low molecular weight heparin

## Key facts

- **NCT ID:** NCT03171727
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-01
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-12-30
- **Target enrollment:** 117 (ESTIMATED)
- **Last updated:** 2019-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03171727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03171727, "Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03171727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*